Temporal Characterization of Behavioral and Hippocampal Dysfunction in the YAC128 Mouse Model of Huntington's Disease

被引:4
|
作者
Nascimento-Castro, Cristine De Paula [1 ]
Winkelmann-Duarte, Elisa C. [2 ]
Mancini, Gianni [1 ]
Welter, Priscilla Gomes [1 ]
Placido, Evelini [1 ]
Farina, Marcelo [1 ,3 ]
Gil-Mohapel, Joana [4 ,5 ]
Rodrigues, Ana Lucia S. [1 ,3 ]
de Bem, Andreza Fabro [3 ]
Brocardo, Patricia S. [1 ,2 ]
机构
[1] Univ Fed Santa Catarina, Ctr Biol Sci, Neurosci Grad Program, BR-88040900 Florianopolis, SC, Brazil
[2] Univ Fed Santa Catarina, Ctr Biol Sci, Dept Morphol Sci, BR-88040900 Florianopolis, SC, Brazil
[3] Univ Fed Santa Catarina, Ctr Biol Sci, Dept Biochem, BR-88040900 Florianopolis, SC, Brazil
[4] Univ Victoria, Div Med Sci, Victoria, BC V8P 5C2, Canada
[5] Univ Victoria, UBC Isl Med Program, Victoria, BC V8P 5C2, Canada
基金
巴西圣保罗研究基金会;
关键词
Huntington's disease; hippocampus; YAC128; mice; electron microscopy; neurodegeneration; ELECTRON-MICROSCOPIC CHARACTERIZATION; DEPRESSIVE-LIKE BEHAVIOR; MUTANT HUNTINGTIN; SELECTIVE DEGENERATION; MITOCHONDRIAL FISSION; PSYCHIATRIC-SYMPTOMS; CELLULAR PATHOLOGY; NEURONAL LOSS; MOTOR; METABOLISM;
D O I
10.3390/biomedicines10061433
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington's disease (HD) is a genetic neurodegenerative disease characterized by motor, psychiatric, and cognitive symptoms. Emerging evidence suggests that emotional and cognitive deficits seen in HD may be related to hippocampal dysfunction. We used the YAC128 HD mouse model to perform a temporal characterization of the behavioral and hippocampal dysfunctions. Early and late symptomatic YAC128 mice exhibited depressive-like behavior, as demonstrated by increased immobility times in the Tail Suspension Test. In addition, YAC128 mice exhibited cognitive deficits in the Swimming T-maze Test during the late symptomatic stage. Except for a reduction in basal mitochondrial respiration, no significant deficits in the mitochondrial respiratory rates were observed in the hippocampus of late symptomatic YAC128 mice. In agreement, YAC128 animals did not present robust alterations in mitochondrial ultrastructural morphology. However, light and electron microscopy analysis revealed the presence of dark neurons characterized by the intense staining of granule cell bodies and shrunken nuclei and cytoplasm in the hippocampal dentate gyrus (DG) of late symptomatic YAC128 mice. Furthermore, structural alterations in the rough endoplasmic reticulum and Golgi apparatus were detected in the hippocampal DG of YAC128 mice by electron microscopy. These results clearly show a degenerative process in the hippocampal DG in late symptomatic YAC128 animals.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease
    Carroll, Jeffrey B.
    Lerch, Jason P.
    Franciosi, Sonia
    Spreeuw, Amanda
    Bissada, Nagat
    Henkelman, R. Mark
    Hayden, Michael R.
    NEUROBIOLOGY OF DISEASE, 2011, 43 (01) : 257 - 265
  • [32] Characterization of subventricular zone-derived progenitor cells from mild and late symptomatic YAC128 mouse model of Huntington's disease
    Silva, Ana C.
    Ferreira, Ildete L.
    Hayden, Michael R.
    Ferreiro, Elisabete
    Rego, A. Cristina
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (01): : 34 - 44
  • [33] TREATMENT WITH ARIMOCLOMOL DOES NOT LEAD TO RESCUE OF MOTOR OR STRIATAL DEFICITS IN THE YAC128 MOUSE MODEL OF HUNTINGTON'S DISEASE
    Pouladi, M. A.
    Carroll, J.
    Santos, R. Dar
    Bertram, L.
    Hayden, M. R.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A14 - A14
  • [34] Impaired Homeostatic Plasticity in YAC128 Huntington's Disease Mouse Cortical Neurons Rescued by Pridopidine
    Smith-Dijak, Amy
    Mackay, James
    Geva, Michal
    Hayden, Michael
    Raymond, Lynn A.
    NEUROTHERAPEUTICS, 2018, 15 (01) : 258 - 258
  • [35] Screening of Therapeutic Strategies for Huntington's Disease in YAC128 Transgenic Mice
    Gil-Mohapel, Joana M.
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (01) : 77 - 86
  • [36] Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models
    Graham, RK
    Slow, EJ
    Deng, Y
    Bissada, N
    Lu, G
    Pearson, J
    Shehadeh, J
    Leavitt, BR
    Raymond, LA
    Hayden, MR
    NEUROBIOLOGY OF DISEASE, 2006, 21 (02) : 444 - 455
  • [37] Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease
    Huang, Kun
    Kang, Martin H.
    Askew, Caitlin
    Kang, Rujun
    Sanders, Shaun S.
    Wan, Junmei
    Davis, Nicholas G.
    Hayden, Michael R.
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 207 - 215
  • [38] Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice
    Garcia-Miralles, Marta
    Geva, Michal
    Tan, Jing Ying
    Yusof, Nur Amirah Binte Mohammad
    Cha, Yoonjeong
    Kusko, Rebecca
    Tan, Liang Juin
    Xu, Xiaohong
    Grossman, Iris
    Orbach, Aric
    Hayden, Michael R.
    Pouladi, Mahmoud A.
    JCI INSIGHT, 2017, 2 (23)
  • [39] Protection by dietary restriction in the YAC128 mouse model of Huntington's disease: Relation to genes regulating histone acetylation and HTT
    Moreno, Cesar L.
    Ehrlich, Michelle E.
    Mobbs, Charles V.
    NEUROBIOLOGY OF DISEASE, 2016, 85 : 25 - 34
  • [40] Age-dependent alterations in the cortical entrainment of subthalamic nucleus neurons in the YAC128 mouse model of Huntington's disease
    Callahan, Joshua W.
    Abercrombie, Elizabeth D.
    NEUROBIOLOGY OF DISEASE, 2015, 78 : 88 - 99